- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04694521
Outcomes of Side-to-end Versus End-to-end Colorectal Anastomosis in Non-emergent Sigmoid and Rectal Cancers: Randomized Controlled Clinical Trial
Introduction: Cancer rectum and sigmoid is increasing nowadays. Resection and anastomosis is done laparoscopic approach with various techniques of anastomosis.
Aim of this study: to compare between open side to end colorectal anastomosis versus laparoscopic end to end colorectal anastomosis in Non-emergent colo- rectal Cancers in adults as regard anastomotic leak, intestinal function and quality of life.
Patients and Methods: Randomized controlled trial was performed on patients with Non-emergent colo rectal cancers between September 2016 and September 2018.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
ICancer rectum prevalence comes next to bronchogenic and prostatic malignant neoplasms in male, but it is the second cancer in female following cancer breast. [1] despite the fact that 1,000,000 patients notably every year and mortality by thousands, yet patients that live from this cancer is surging in the last years due to both sumptuous appliance of investigation and novel intervention techniques. Over two thirds of rectal cancer patients survived 5 years. [2].
Colorectal surgery principles target to merge the fulfillment of well-balanced free margin resection with bowel, urinary and potency activities. [3]. Laparoscopic rectal surgery for cancer had a famed corner in recent surgery that besieged open approach [4]. Rectal surgery has many troubles. The most troubled complication is anastomotic leakage. The prevalence of anastomotic leakage following rectal resection and anastomosis may wave to 15% of cases with high morbidity and mortality [5].The inauguration of the stapler in rectal surgery assisted the anastomosis to be in a homogeneous design, decrease strain on the suture, speedy surgery, no intra-abdominal contamination, no intrusion of anastomotic site perfusion and narrow the prevalence of anastomotic leakage. [6]. Resection of rectum is linked to low anterior resection syndrome (LARS) that usually affects quality of life [7].
2. Aim of the work, gap statement and strength of the study: During rectal cancer surgery, no conclusive path of resection and anastomosis and usually followed by the surgeons according to their experience. In the current study, we have organized a randomized clinical trial to analyze the outcomes in two groups of patients with colo rectum cancers with two different laparoscopic approaches for resection and anastomosis. The primary aim was to correlate the prevalence of anastomotic leak after both interventions. The secondary aim was to appraise intestinal functional outcome and quality of life between both groups.
Patients & Methods:
3.1 Study design and study power: This is a prospective randomized controlled trial managed in the colorectal surgical units of our University Hospitals (solitary-center) between September 2016 to September 2018. A total of 74 patients diagnosed as colorectal cancer underwent openrectal cancer surgery. The patients were randomly labeled into two groups: Group (A): included 37 patients: open side to end colorectal anastomosis (SEA) and Group (B): included 37 patients: openend to end colorectal anastomosis (EEA). As percentage of leakage from previous paper [8] was 29% VS 5.4% so sample will be 37 in each group with power 80% and confidence level 95% would be suitable to reach statistical significance (p<0.05). It is a simple random sample with a balance. Patients were randomly allocated using a random sequence computer. Patients were randomly numbered in closed envelopes, which were opened just before accomplishing the anastomosis intraoperative. Patients were unaware to the any group until after the study. It is the role of registration office.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
1. colo rectum adenocarcinoma proved by biopsy and histo-pathological examination.
2. Only resections performed with immediate anastomosis, not under cover of stoma.
3. Expected R0 resection. 4. patients >18 years ,both sex 6. No previous history of stool or flatus incontinence, and clinically normal function of anal sphincter.
Exclusion Criteria:
- Patients younger than 18 years , Pregnant female.
- Inability to understand the informed consent or refuse to participate or psychiatric patients.
- Patients with recurrent cancer, Irresectable tumour, widespread loco-regional, distant metastasis ,Combination operation and Complicated cancer e.g. obstructed or perforated.
- Cases covered by proximal stoma.
- Patients with lesion <3 cm from anal verge or cancer involving anal sphincter
- preoperative chemo radiotherapy
Previous left sided colorectal surgery or anorectal surgeries.
-
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: antegrade colorectal single stapler anastomosis
open Side to end antegrade colorectal anastomosis colo rectal cancers.
|
open Side to end colorectal anastomosis
|
|
EXPERIMENTAL: open end to end colorectal stapler anastomosis
open end to end colorectal single anastomosis in non-emergent colo rectal cancers.
|
open end to end stapler anastomosis
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
: the incidence of the anastomotic leak during hospital admission and during 30 days postoperative.
Time Frame: 30 days
|
: the incidence of the anastomotic leak during hospital admission and during 30 days postoperative.
|
30 days
|
|
intestinal function
Time Frame: 24 months after surgery.
|
intestinal function and LAR score
|
24 months after surgery.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
the overall postoperative morbidities
Time Frame: within 90 days
|
the overall postoperative morbidities by clavien-dindo classification
|
within 90 days
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- zagazig university 2
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gastrointestinal Neoplasms
-
Medstar Health Research InstituteRecruitingGastrointestinal Cancer | Gastrointestinal Tumor | Gastrointestinal Surgery | Gastrointestinal Tumor SurgeryUnited States
-
Sun Yat-sen UniversityUnknownGastrointestinal CancersChina
-
H. Lee Moffitt Cancer Center and Research InstituteNovartisCompleted
-
Peking University Cancer Hospital & InstituteActive, not recruitingGastrointestinal CancerChina
-
Suzhou Zelgen Biopharmaceuticals Co.,LtdJiangsu Alphamab Biopharmaceuticals Co., LtdTerminatedAdvanced Gastrointestinal TumorsChina
-
Boehringer IngelheimCompletedGastrointestinal Cancer, MetastaticBelgium, United States, France, Japan, China
-
Taiho Oncology, Inc.CompletedAdvanced Gastrointestinal TumorsUnited States
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Henan Cancer HospitalUnknownAdvanced Gastrointestinal TumorsChina
-
Apceth GmbH & Co. KGTerminatedAdvanced Gastrointestinal CancerGermany
Clinical Trials on openSide to end colorectal anastomosis .
-
Tianjin Medical University Cancer Institute and...RecruitingEpiphora Due to Insufficient Drainage, Left Side | Epiphora Due to Insufficient Drainage, Right SideChina
-
Sawai Mansingh Medical CollegeCompletedIleus | Bowel Obstruction | Stoma Ileostomy | Anastomosis | Stoma Colostomy | Leak, AnastomoticIndia
-
Umeå UniversitySkane University Hospital; Sahlgrenska University HospitalRecruitingColorectal Cancer | Diverticular Disease of Left Side of Colon | Anastomotic Leakage | Colorectal AnastomosisSweden
-
Weill Medical College of Cornell UniversityThe Leona M. and Harry B. Helmsley Charitable Trust; Crohn's and Colitis FoundationRecruitingCrohn's DiseaseUnited States, Germany, Belgium, Italy, Finland, Spain
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Dutch Digestive Diseases Foundation; Commission of Applied Clinical Research...Completed
-
Ludwig-Maximilians - University of MunichUnknownRectal Cancer | Rectal Neoplasms | Fecal Incontinence | Rectal TumorsGermany
-
National and Kapodistrian University of AthensNot yet recruitingColorectal Anastomosis
-
Swiss Group for Clinical Cancer ResearchCompletedColorectal CancerSwitzerland, Germany
-
Charite University, Berlin, GermanyChirNetUnknown
-
Minia UniversityRecruitingColorectal Cancer | Anastomotic Leak | DiverticulitisEgypt